Published in:
Open Access
01-12-2021 | Aortic Valve Replacement | Case report
ACURATE neo™ aortic valve implantation via carotid artery access: first case report
Authors:
Chadi Aludaat, Alexandre Canville, Quentin Landolff, Matthieu Godin, Fabrice Bauer, Fabien Doguet
Published in:
Journal of Cardiothoracic Surgery
|
Issue 1/2021
Login to get access
Abstract
Background
The ACURATE neo™ transcatheter heart valve (Boston Scientific, Marlborough, Massachusetts) is predominantly implanted via femoral access. Transcarotid use of this prothesis has never been reported.
Case presentation
We present the case of an 89-year-old woman referred to us for a transcatheter aortic valve replacement (TAVR). After apparatus imaging of the aortic annulus and the peripheral vascular pathway, the heart team was confronted with a triple challenge: (i) The preferable choice of a self-expanding valve because of a small aortic annulus in an obese woman. (ii) Gaining favorable access to the coronary ostia, considering multiple recent coronary stenting. (iii) Utilizing an alternative arterial access because of iliac and femoral severely calcified stenosis. Implanting the ACURATE neo™ transcatheter heart valve (THV) via carotidal access allowed us to overcome these challenges. The procedure was performed successfully without any short-term complications.
Conclusion
We report the first case of implantation of an ACURATE neo™ transcatheter heart valve (Boston Scientific, Marlborough, Massachusetts) via the right common carotid artery.